vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and CPI Card Group Inc. (PMTS). Click either name above to swap in a different company.
CPI Card Group Inc. is the larger business by last-quarter revenue ($153.1M vs $123.8M, roughly 1.2× NATURES SUNSHINE PRODUCTS INC). CPI Card Group Inc. runs the higher net margin — 4.8% vs 3.3%, a 1.5% gap on every dollar of revenue. On growth, CPI Card Group Inc. posted the faster year-over-year revenue change (22.3% vs 4.7%). CPI Card Group Inc. produced more free cash flow last quarter ($35.2M vs $7.6M). Over the past eight quarters, CPI Card Group Inc.'s revenue compounded faster (16.9% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
NATR vs PMTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $153.1M |
| Net Profit | $4.1M | $7.3M |
| Gross Margin | 72.5% | 31.5% |
| Operating Margin | 4.3% | 12.0% |
| Net Margin | 3.3% | 4.8% |
| Revenue YoY | 4.7% | 22.3% |
| Net Profit YoY | 1379.4% | 8.5% |
| EPS (diluted) | $0.23 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $153.1M | ||
| Q3 25 | $128.3M | $138.0M | ||
| Q2 25 | $114.8M | $129.8M | ||
| Q1 25 | $113.2M | $122.8M | ||
| Q4 24 | $118.2M | $125.1M | ||
| Q3 24 | $114.6M | $124.8M | ||
| Q2 24 | $110.6M | $118.8M | ||
| Q1 24 | $111.0M | $111.9M |
| Q4 25 | $4.1M | $7.3M | ||
| Q3 25 | $5.3M | $2.3M | ||
| Q2 25 | $5.3M | $518.0K | ||
| Q1 25 | $4.7M | $4.8M | ||
| Q4 24 | $-321.0K | $6.8M | ||
| Q3 24 | $4.3M | $1.3M | ||
| Q2 24 | $1.3M | $6.0M | ||
| Q1 24 | $2.3M | $5.5M |
| Q4 25 | 72.5% | 31.5% | ||
| Q3 25 | 73.3% | 29.7% | ||
| Q2 25 | 71.7% | 30.9% | ||
| Q1 25 | 72.1% | 33.2% | ||
| Q4 24 | 72.0% | 34.1% | ||
| Q3 24 | 71.3% | 35.8% | ||
| Q2 24 | 71.4% | 35.7% | ||
| Q1 24 | 71.2% | 37.1% |
| Q4 25 | 4.3% | 12.0% | ||
| Q3 25 | 7.0% | 9.4% | ||
| Q2 25 | 3.7% | 7.3% | ||
| Q1 25 | 5.4% | 11.5% | ||
| Q4 24 | 3.8% | 12.7% | ||
| Q3 24 | 4.6% | 14.3% | ||
| Q2 24 | 5.1% | 12.5% | ||
| Q1 24 | 4.2% | 12.6% |
| Q4 25 | 3.3% | 4.8% | ||
| Q3 25 | 4.2% | 1.7% | ||
| Q2 25 | 4.6% | 0.4% | ||
| Q1 25 | 4.2% | 3.9% | ||
| Q4 24 | -0.3% | 5.4% | ||
| Q3 24 | 3.8% | 1.0% | ||
| Q2 24 | 1.2% | 5.1% | ||
| Q1 24 | 2.1% | 4.9% |
| Q4 25 | $0.23 | $0.62 | ||
| Q3 25 | $0.30 | $0.19 | ||
| Q2 25 | $0.28 | $0.04 | ||
| Q1 25 | $0.25 | $0.40 | ||
| Q4 24 | $-0.02 | $0.56 | ||
| Q3 24 | $0.23 | $0.11 | ||
| Q2 24 | $0.07 | $0.51 | ||
| Q1 24 | $0.12 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $21.7M |
| Total DebtLower is stronger | — | $286.7M |
| Stockholders' EquityBook value | $161.6M | $-17.3M |
| Total Assets | $261.1M | $403.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $21.7M | ||
| Q3 25 | $95.6M | $16.0M | ||
| Q2 25 | $81.3M | $17.1M | ||
| Q1 25 | $86.5M | $31.5M | ||
| Q4 24 | $84.7M | $33.5M | ||
| Q3 24 | $78.7M | $14.7M | ||
| Q2 24 | $68.7M | $7.5M | ||
| Q1 24 | $77.8M | $17.1M |
| Q4 25 | — | $286.7M | ||
| Q3 25 | — | $308.4M | ||
| Q2 25 | — | $310.9M | ||
| Q1 25 | — | $280.7M | ||
| Q4 24 | — | $280.4M | ||
| Q3 24 | — | $280.2M | ||
| Q2 24 | — | $269.7M | ||
| Q1 24 | $2.1M | $265.3M |
| Q4 25 | $161.6M | $-17.3M | ||
| Q3 25 | $166.7M | $-25.7M | ||
| Q2 25 | $163.7M | $-29.0M | ||
| Q1 25 | $167.1M | $-29.7M | ||
| Q4 24 | $161.0M | $-35.6M | ||
| Q3 24 | $162.6M | $-42.8M | ||
| Q2 24 | $156.4M | $-44.6M | ||
| Q1 24 | $159.7M | $-48.5M |
| Q4 25 | $261.1M | $403.2M | ||
| Q3 25 | $264.8M | $407.1M | ||
| Q2 25 | $254.9M | $399.8M | ||
| Q1 25 | $252.7M | $351.9M | ||
| Q4 24 | $240.9M | $349.7M | ||
| Q3 24 | $245.3M | $342.3M | ||
| Q2 24 | $235.8M | $321.4M | ||
| Q1 24 | $247.3M | $319.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $39.6M |
| Free Cash FlowOCF − Capex | $7.6M | $35.2M |
| FCF MarginFCF / Revenue | 6.1% | 23.0% |
| Capex IntensityCapex / Revenue | 1.9% | 2.9% |
| Cash ConversionOCF / Net Profit | 2.41× | 5.39× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $41.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $39.6M | ||
| Q3 25 | $18.5M | $10.0M | ||
| Q2 25 | $4.3M | $4.3M | ||
| Q1 25 | $2.6M | $5.6M | ||
| Q4 24 | $12.2M | $26.7M | ||
| Q3 24 | $9.6M | $12.5M | ||
| Q2 24 | $1.3M | $-4.8M | ||
| Q1 24 | $2.2M | $8.9M |
| Q4 25 | $7.6M | $35.2M | ||
| Q3 25 | $16.8M | $5.3M | ||
| Q2 25 | $3.0M | $533.0K | ||
| Q1 25 | $1.5M | $292.0K | ||
| Q4 24 | $10.0M | $21.6M | ||
| Q3 24 | $7.9M | $11.1M | ||
| Q2 24 | $-2.0M | $-6.0M | ||
| Q1 24 | $-1.5M | $7.4M |
| Q4 25 | 6.1% | 23.0% | ||
| Q3 25 | 13.1% | 3.8% | ||
| Q2 25 | 2.6% | 0.4% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 8.5% | 17.3% | ||
| Q3 24 | 6.9% | 8.9% | ||
| Q2 24 | -1.9% | -5.0% | ||
| Q1 24 | -1.4% | 6.6% |
| Q4 25 | 1.9% | 2.9% | ||
| Q3 25 | 1.3% | 3.4% | ||
| Q2 25 | 1.2% | 2.9% | ||
| Q1 25 | 1.0% | 4.3% | ||
| Q4 24 | 1.9% | 4.0% | ||
| Q3 24 | 1.5% | 1.2% | ||
| Q2 24 | 3.0% | 1.0% | ||
| Q1 24 | 3.3% | 1.3% |
| Q4 25 | 2.41× | 5.39× | ||
| Q3 25 | 3.46× | 4.32× | ||
| Q2 25 | 0.81× | 8.39× | ||
| Q1 25 | 0.55× | 1.17× | ||
| Q4 24 | — | 3.94× | ||
| Q3 24 | 2.21× | 9.70× | ||
| Q2 24 | 0.97× | -0.79× | ||
| Q1 24 | 0.94× | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
